Skip to main content
SpringerLink
Log in

Clinical Presentation, Diagnosis, and Management of Uncommon Liver Tumors

  • Reference work entry
  • First Online:
Hepato-Pancreato-Biliary Malignancies

  • 662 Accesses

Abstract

Aside from hepatocellular carcinoma, cholangiocarcinoma, or hepatic metastases, some hepatic lesions are exceedingly rare. Given the rarity of some hepatic lesions, arriving at a definitive diagnosis and management plan can be particularly challenging. In this chapter, we present an overview of clinical presentations, diagnosis, and management of uncommon hepatic tumors derived from available literature.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 329.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Zheng Y, Zhang X, Zhang J, Hui Z, Du W, Li R, et al. Primary hepatic angiosarcoma and potential treatment options. J Gastroenterol Hepatol. 2014;29(5):906–11.

    CAS  Google Scholar 

  2. Fields BKK, Matcuk GR, Lai D, Lee A, Dwabe S, Hanlon C, et al. Primary hepatic angiosarcoma: a case-based discussion of unique presentations and extrahepatic manifestations. Curr Probl Cancer: Case Rep. 2020;1:100012.

    Google Scholar 

  3. Montell García M, Romero Cabello R, Romero Feregrino R, Atri Moises M, Trejo Estrada R, Alvaro P-R, et al. Angiosarcoma of the liver as a cause of fulminant liver failure. BMJ Case Rep. 2012; [cited 2020 Aug 11]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4543703/

  4. Koyama T, Fletcher JG, Johnson CD, Kuo MS, Notohara K, Burgart LJ. Primary hepatic angiosarcoma: findings at CT and MR Imaging1. Radiology. 2002; [cited 2020 Mar 6]; Available from: https://pubs.rsna.org/doi/abs/10.1148/radiol.2223010877

  5. Li Z, Sun H, Shen C, Yang C, Wang Y, Wang W, et al. Primary hepatic angiosarcoma with spleen metastases in an adult woman: a case report and literature review. Int J Clin Exp Pathol. 2017;10(11):11211–8.

    Google Scholar 

  6. Lazăr DC, Avram MF, Romoșan I, Văcariu V, Goldiș A, Cornianu M. Malignant hepatic vascular tumors in adults: Characteristics, diagnostic difficulties and current management. World J Clin Oncol. 2019;10(3):110–35.

    Google Scholar 

  7. Drinković I, Brkljačić B. Two cases of lethal complications following ultrasound-guided percutaneous fine-needle biopsy of the liver. Cardiovasc Intervent Radiol. 1996;19(5):360–3.

    Google Scholar 

  8. Geller RL, Hookim K, Sullivan HC, Stuart LN, Edgar MA, Reid MD. Cytologic features of angiosarcoma: a review of 26 cases diagnosed on FNA. Cancer Cytopathol. 2016;124(9):659–68.

    CAS  Google Scholar 

  9. Chien C-Y, Hwang C, Yeh C, Chen H, Wu J-T, Cheung C-S, et al. Liver angiosarcoma, a rare liver malignancy, presented with intraabdominal bleeding due to rupture – a case report. World J Surg Oncol. 2012;10:23.

    Google Scholar 

  10. Zhu Y-P, Chen Y-M, Matro E, Chen R-B, Jiang Z-N, Mou Y-P, et al. Primary hepatic angiosarcoma: a report of two cases and literature review. World J Gastroenterol. 2015;21(19):6088–96.

    Google Scholar 

  11. Tripke V, Heinrich S, Huber T, Mittler J, Hoppe-Lotichius M, Straub BK, et al. Surgical therapy of primary hepatic angiosarcoma. BMC Surg. 2019;19. [cited 2020 Mar 6];19. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329081/

  12. Orlando G, Adam R, Mirza D, Soderdahl G, Porte RJ, Paul A, et al. Hepatic hemangiosarcoma: an absolute contraindication to liver transplantation – the European liver transplant registry experience. Transplantation. 2013;95(6):872–7.

    Google Scholar 

  13. Penel N, Bui BN, Bay J-O, Cupissol D, Ray-Coquard I, Piperno-Neumann S, et al. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX study. J Clin Oncol. 2008;26(32):5269–74.

    CAS  Google Scholar 

  14. Agulnik M, Yarber JL, Okuno SH, von Mehren M, Jovanovic BD, Brockstein BE, et al. An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol. 2013;24(1):257–63.

    CAS  Google Scholar 

  15. Ray-Coquard I, Italiano A, Bompas E, Le Cesne A, Robin Y-M, Chevreau C, et al. Sorafenib for patients with advanced angiosarcoma: a phase II trial from the French Sarcoma Group (GSF/GETO). Oncologist. 2012;17(2):260–6.

    CAS  Google Scholar 

  16. Mistry AM, Gorden DL, Busler JF, Coogan AC, Kelly BS. Diagnostic and therapeutic challenges in hepatic epithelioid hemangioendothelioma. J Gastrointest Cancer. 2012;43(4):521–5.

    Google Scholar 

  17. Mehrabi A, Kashfi A, Fonouni H, Schemmer P, Schmied BM, Hallscheidt P, et al. Primary malignant hepatic epithelioid hemangioendothelioma. Cancer. 2006;107(9):2108–21.

    Google Scholar 

  18. Yang J-W, Li Y, Xie K, Dong W, Cao X-T, Xiao W-D. Spontaneous rupture of hepatic epithelioid hemangioendothelioma: a case report. World J Gastroenterol. 2017;23(1):185–90.

    Google Scholar 

  19. Zis P, Assi A, Kravaritis D, Sevastianos VA. Ischemic stroke as the first manifestation of hepatic epithelioid hemangioendothelioma. J Stroke Cerebrovasc Dis. 2014;23(3):e237–40.

    Google Scholar 

  20. Neofytou K, Chrysochos A, Charalambous N, Dietis M, Petridis C, Andreou C, et al. Hepatic epithelioid hemangioendothelioma and the danger of misdiagnosis: report of a case. Case Rep Oncol Med. 2013; [cited 2021 Jan 24]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600255/

  21. Lyburn ID, Torreggiani WC, Harris AC, Zwirewich CV, Buckley AR, Davis JE, et al. Hepatic epithelioid hemangioendothelioma: sonographic, CT, and MR imaging appearances. Am J Roentgenol. 2003;180(5):1359–64.

    Google Scholar 

  22. Alomari AI. The lollipop sign: a new cross-sectional sign of hepatic epithelioid hemangioendothelioma. Eur J Radiol. 2006;59(3):460–4.

    Google Scholar 

  23. Liu YI, Brown SS, Elihu A, Bonham CA, Concepcion W, Longacre TA, et al. Hepatic epithelioid hemangioendothelioma. Dig Dis Sci. 2011;56(2):303–6.

    Google Scholar 

  24. Choi KH, Moon WS. Epithelioid hemangioendothelioma of the liver. Clin Mol Hepatol. 2013;19(3):315.

    Google Scholar 

  25. Rodriguez JA, Becker NS, O’Mahony CA, Goss JA, Aloia TA. Long-term outcomes following liver transplantation for hepatic hemangioendothelioma: the UNOS experience from 1987 to 2005. J Gastrointest Surg. 2008;12(1):110–6.

    Google Scholar 

  26. Remiszewski P, Szczerba E, Kalinowski P, Gierej B, Dudek K, Grodzicki M, et al. Epithelioid hemangioendothelioma of the liver as a rare indication for liver transplantation. World J Gastroenterol. 2014;20(32):11333–9.

    Google Scholar 

  27. Soape MP, Verma R, Payne JD, Wachtel M, Hardwicke F, Cobos E. Treatment of hepatic epithelioid hemangioendothelioma: finding uses for thalidomide in a new era of medicine. Case Rep Gastrointest Med. 2015; [cited 2021 Jan 24]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488146/

  28. Cao Q, Ye Z, Chen S, Liu N, Li S, Liu F. Undifferentiated embryonal sarcoma of liver: a multi-institutional experience with 9 cases. Int J Clin Exp Pathol. 2014;7(12):8647–56.

    Google Scholar 

  29. Lenze F, Birkfellner T, Lenz P, Hussein K, Länger F, Kreipe H, et al. Undifferentiated embryonal sarcoma of the liver in adults. Cancer. 2008;112(10):2274–82.

    Google Scholar 

  30. Yedibela S, Reck T, Ott R, Müller V, Papadopoulos T, Hohenberger W. Undifferenziertes, embryonales Sarkom als seltene Ursache einer Leberruptur beim Erwachsenen. Chirurg. 2000;71(1):101–5.

    CAS  Google Scholar 

  31. Pandit N, Jaiswal LS, Shrestha V, Awale L, Adhikary S. Undifferentiated embryonal sarcoma of liver in an adult with spontaneous rupture and tumour thrombus in the right atrium. ANZ J Surg. 2019;89(9):E396–7.

    Google Scholar 

  32. Li X-W, Gong S-J, Song W-H, Zhu J-J, Pan C-H, Wu M-C, et al. Undifferentiated liver embryonal sarcoma in adults: a report of four cases and literature review. World J Gastroenterol. 2010;16(37):4725–32.

    Google Scholar 

  33. Kallam A, Krishnamurthy J, Kozel J, Shonka N. Undifferentiated embryonal sarcoma of liver. Rare Tumors. 2015;7(4) [cited 2020 Aug 16]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703922/

  34. Naveen K, Sameer V, Palash JD, Rakesh K, Radhika S, Niranjan K. Undifferentiated embryonal sarcoma of liver in an adult masquerading as complicated hydatid cyst. Ann Hepatol. 2011;10(1):81–3.

    Google Scholar 

  35. Walther A, Geller J, Coots A, Towbin A, Nathan J, Alonso M, et al. Multimodal therapy including liver transplantation for hepatic undifferentiated embryonal sarcoma. Liver Transpl. 2014;20(2):191–9.

    Google Scholar 

  36. Mori A, Fukase K, Masuda K, Sakata N, Mizuma M, Ohtsuka H, et al. A case of adult undifferentiated embryonal sarcoma of the liver successfully treated with right trisectionectomy: a case report. Surg Case Rep. 2017;3. [cited 2020 Aug 22]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5285294/

  37. Plumblee L, Grey H, Hudspeth M, Nadig S. Undifferentiated embryonal sarcoma and the role of liver transplantation. J Pediatr Surg Case Rep. 2019;49:101284.

    Google Scholar 

  38. Portolani N, Baiocchi GL, Coniglio A, Piardi T, Grazioli L, Benetti A, et al. Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a western experience. Ann Surg Oncol. 2008;15(7):1880–90.

    Google Scholar 

  39. Fowler KJ, Sheybani A, Parker RA, Doherty S, M Brunt E, Chapman WC, et al. Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI. Am J Roentgenol. 2013;201(2):332–9.

    Google Scholar 

  40. Ebied O, Federle MP, Blachar A, Brancatelli G, Grazioli L, Cazals-Hatem D, et al. Hepatocellular-cholangiocarcinoma: helical computed tomography findings in 30 patients. J Comput Assist Tomogr. 2003;27(2):117–24.

    Google Scholar 

  41. Panjala C, Senecal DL, Bridges MD, Kim GP, Nakhleh RE, Nguyen JHH, et al. The diagnostic conundrum and liver transplantation outcome for combined hepatocellular-cholangiocarcinoma. Am J Transplant. 2010;10(5):1263–7.

    CAS  Google Scholar 

  42. Aoki K, Takayasu K, Kawano T, Muramatsu Y, Moriyama N, Wakao F, et al. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features and computed tomographic findings. Hepatology. 1993;18(5):1090–5.

    CAS  Google Scholar 

  43. Ye J, Xie X, Lin Y, Liu B, Wang W, Huang X, et al. Imaging features of combined hepatocellular–cholangiocarcinoma on contrast-enhanced ultrasound: correlation with clinicopathological findings. Clin Radiol. 2018;73(3):237–43.

    CAS  Google Scholar 

  44. Gera S, Ettel M, Acosta-Gonzalez G, Xu R. Clinical features, histology, and histogenesis of combined hepatocellular-cholangiocarcinoma. World J Hepatol. 2017;9(6):300–9.

    Google Scholar 

  45. Yin X, Zhang B-H, Qiu S-J, Ren Z-G, Zhou J, Chen X-H, et al. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis. Ann Surg Oncol. 2012;19(9):2869–76.

    Google Scholar 

  46. Chi M, Mikhitarian K, Shi C, Goff LW. Management of combined hepatocellular-cholangiocarcinoma: a case report and literature review. Gastrointest Cancer Res. 2012;5(6):199–202.

    Google Scholar 

  47. Naik PRT, Kumar P, Kumar PV. Primary pleomorphic liposarcoma of liver: a case report and review of the literature. Case Rep Hepatol. 2013; [cited 2020 Aug 29]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4208437/

  48. Binesh F, Akhavan A, Kargar S, Navabii H. Primary liposarcoma of liver: a rare case and literature review. BMJ Case Rep. 2012; [cited 2020 Aug 29]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4543104/

  49. Nelson V, Fernandes NF, Woolf GM, Geller SA, Petrovic LM. Primary liposarcoma of the liver: a case report and review of the literature. Arch Pathol Lab Med. 2001;125(3):410–2.

    CAS  Google Scholar 

  50. Liu W, Liang W, Peng Z. Positron emission tomography/computed tomography manifestations of primary hepatic myxoid liposarcoma. Medicine (Baltimore). 2018;97(39) [cited 2020 Aug 29]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6181573/

  51. Mehta N, Jayapal L, Goneppanavar M, Nelamangala Ramakrishnaiah VP. Primary hepatic lymphoma: a rare case report. JGH Open. 2019;3(3):261–3.

    Google Scholar 

  52. Agmon-Levin N, Berger I, Shtalrid M, Schlanger H, Sthoeger ZM. Primary hepatic lymphoma: a case report and review of the literature. Age Ageing. 2004;33(6):637–40. https://doi.org/10.1093/ageing/afh197. Epub 2004 Sep 20. PMID: 15381504.

  53. Mastoraki A, Stefanou MI, Chatzoglou E, Danias N, Kyriazi M, Arkadopoulos N, et al. Primary hepatic lymphoma: dilemmas in diagnostic approach and therapeutic management. Indian J Hematol Blood Transfus. 2014;30(3):150–4.

    Google Scholar 

  54. Yang X-W, Tan W-F, Yu W-L, Shi S, Wang Y, Zhang Y-L, et al. Diagnosis and surgical treatment of primary hepatic lymphoma. World J Gastroenterol. 2010;16(47):6016–9.

    Google Scholar 

  55. Ugurluer G, Miller RC, Li Y, Thariat J, Ghadjar P, Schick U, et al. Primary hepatic lymphoma: a retrospective, multicenter rare cancer network study. Rare Tumors. 2016;8(3) [cited 2020 Aug 30]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064304/

  56. Myoteri D, Dellaportas D, Arkoumani E, Marinis A, Zizi-Sermpetzoglou A. Primary hepatic lymphoma: a challenging diagnosis. Case Rep Oncol Med. 2014;2014:1–3.

    Google Scholar 

  57. Schoofs, G & Braeye, Lieve & Vanheste, R & Verswijvel, Geert & Debiec-Rychter, Maria & Sciot, Raf. (2011). Hepatic rhabdomyosarcoma in an adult: A rare primary malignant liver tumor. case report and literature review. Acta gastro-enterologica Belgica. 74:576–81.

    Google Scholar 

  58. Yin J, Liu Z, Yang K. Pleomorphic rhabdomyosarcoma of the liver with a hepatic cyst in an adult. Medicine (Baltimore). 2018;97(29) [cited 2021 Jan 17]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086459/

  59. Okazaki M, Tajima H, Ohbatake Y, Shinbashi H, Nakanuma S, Makino I, et al. Pleomorphic rhabdomyosarcoma of the liver in an adult: a rare case report. BMC Surg. 2020;20. [cited 2021 Jan 17]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171846/

  60. Arora A, Jaiswal R, Anand N, Husain N. Primary embryonal rhabdomyosarcoma of the liver. BMJ Case Rep. 2016; [cited 2021 Jan 17]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237799/

  61. Chaudhari V. Management of fibrolamellar hepatocellular carcinoma.

    Google Scholar 

  62. Chagas AL, Kikuchi L, Herman P, Alencar RSSM, Tani CM, Diniz MA, et al. Clinical and pathological evaluation of fibrolamellar hepatocellular carcinoma: a single center study of 21 cases. Clinics (Sao Paulo). 2015;70(3):207–13.

    Google Scholar 

  63. Riggle KM, Turnham R, Scott JD, Yeung RS, Riehle KJ. Fibrolamellar hepatocellular carcinoma: mechanistic distinction from adult hepatocellular carcinoma. Pediatr Blood Cancer. 2016;63(7):1163–7.

    Google Scholar 

  64. Kassahun WT. Contemporary management of fibrolamellar hepatocellular carcinoma: diagnosis, treatment, outcome, prognostic factors, and recent developments. World J Surg Oncol. 2016;14. [cited 2020 Aug 29]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877801/

  65. Malouf GG, Brugières L, Deley M-CL, Faivre S, Fabre M, Paradis V, et al. Pure and mixed fibrolamellar hepatocellular carcinomas differ in natural history and prognosis after complete surgical resection. Cancer. 2012;118(20):4981–90.

    Google Scholar 

  66. Atienza LG, Berger J, Mei X, Shah MB, Daily MF, Grigorian A, et al. Liver transplantation for fibrolamellar hepatocellular carcinoma: a national perspective. J Surg Oncol. 2017;115(3):319–23.

    Google Scholar 

  67. Bauer U, Mogler C, Braren RF, Algül H, Schmid RM, Ehmer U. Progression after immunotherapy for fibrolamellar carcinoma. Visc Med. 2019;35(1):39–42.

    Google Scholar 

  68. Gras P, Truant S, Boige V, Ladrat L, Rougier P, Pruvot F-R, et al. Prolonged complete response after GEMOX chemotherapy in a patient with advanced fibrolamellar hepatocellular carcinoma. Case Rep Oncol. 2012;5(1):169–72.

    Google Scholar 

  69. Zheng MH, Zhang L, Gu DN, Shi HQ, Zeng QQ, Chen YP. Hepatoblastoma in adult: review of the literature. J Clin Med Res. 2009;1(1):13–6.

    Google Scholar 

  70. Wang YX, Liu H. Adult hepatoblastoma: systemic review of the English literature. Dig Surg. 2012;29(4):323–30.

    CAS  Google Scholar 

  71. Cienfuegos JA, Labiano T, Pedano N, Zozaya GN, Martí-Cruchaga P, Panizo Á, et al. Adult hepatoblastoma. Rev Esp Enferm Dig. 2013;105(4):229–31.

    Google Scholar 

  72. Rougemont A-L. Adult hepatoblastoma: learning from children. J Hepatol. 2012;56:12.

    Google Scholar 

  73. Di Benedetto F, Di Sandro S, D’Amico G, De Santis M, Gerunda GE. Role of chemoembolization as a rescue treatment for recurrence of resected hepatoblastoma in adult patients. Surg Innov. 2011;18(2):136–40.

    Google Scholar 

  74. Günster SA, Kim M, Lock JF, Krajinovic K. Hepatic angiomyolipoma: a case report and literature review. Int J Surg Case Rep. 2020;77:345–8.

    Google Scholar 

  75. Liu J, Zhang C-W, Hong D-F, Tao R, Chen Y, Shang M-J, et al. Primary hepatic epithelioid angiomyolipoma: a malignant potential tumor which should be recognized. World J Gastroenterol. 2016;22(20):4908–17.

    CAS  Google Scholar 

  76. Yang C-Y, Ho M-C, Jeng Y-M, Hu R-H, Wu Y-M, Lee P-H. Management of hepatic angiomyolipoma. J Gastrointest Surg. 2007;11(4):452–7.

    Google Scholar 

  77. Ren N, Qin L-X, Tang Z-Y, Wu Z-Q, Fan J. Diagnosis and treatment of hepatic angiomyolipoma in 26 cases. World J Gastroenterol. 2003;9(8):1856–8.

    Google Scholar 

  78. Klompenhouwer AJ, Verver D, Janki S, Bramer WM, Doukas M, Dwarkasing RS, et al. Management of hepatic angiomyolipoma: a systematic review. Liver Int. 2017;37(9):1272–80.

    Google Scholar 

  79. Blokhin I, Chernina V, Menglibaev M, Kalinin D, Schima W, Karmazanovsky G. Giant hepatic angiomyolipoma: a case report. BJR Case Rep. 2018;5(1) [cited 2021 Jan 18]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519506/

  80. Bakhotmah MA, Yamasaki S. Hepatic angiomyolipoma. HPB Surg. 1994;8(2):133–8.

    CAS  Google Scholar 

  81. Tsui WMS, Colombari R, Portmann BC, Bonetti F, Thung SN, Ferrell LD, et al. Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants. Am J Surg Pathol. 1999;23(1):34–48.

    CAS  Google Scholar 

  82. Chen L, Xu MY, Chen F. Bile duct adenoma: a case report and literature review. World J Surg Oncol. 2014;12:125.

    Google Scholar 

  83. Chuy JA, Garg I, Graham RP, VanBuren WM, Venkatesh SK. Imaging features of bile duct adenoma: case series and review of literature. Diagn Interv Radiol. 2018;24(5):249–54.

    Google Scholar 

  84. Valerieva Y, Lutakov I, Golemanov B, Jelev G, Vladimirov B. A rare case of incidental common bile duct adenoma-endoscopic ultrasound evaluation. Balkan Med J. 2018;35(4):346–7.

    Google Scholar 

  85. Ahadi M, Khosravi Khorashad A, Saadatnia H, Vosoughinia H, Davachi B, Farzanehfar M, et al. Resolution of bile duct adenoma over follow-up period; a case report. Middle East J Dig Dis. 2016;8(4):327–30.

    Google Scholar 

  86. Peh KH. Biliary cystadenoma: a rare occurrence. 2.

    Google Scholar 

  87. Xu R-M, Li X-R, Liu L-H, Zheng W-Q, Zhou H, Wang X-C. Intrahepatic biliary cystadenoma: a case report. World J Clin Cases. 2020;8(22):5670–7.

    Google Scholar 

  88. Williamson J, Rees J, Pope I, Strickland A. Hepatobiliary cystadenomas. Ann R Coll Surg Engl. 2013;95(7):507–10.

    CAS  Google Scholar 

  89. Bartolome MAH, Ruiz SF, Romero IM, Lojo BR, Prieto IR, Alvira LG, et al. Biliary cystadenoma. World J Gastroenterol. 2009;15(28):3573–5.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Connecticut GI, Hartford, CT, USA

    Elizabeth Richardson

  2. Main Line Gastroenterology Associates, Collegeville, PA, USA

    Scott Fink

  3. University of Michigan, Ann Arbor, MI, USA

    Jessica Fried

  4. CT Gastroenterology Associates, Hartford, CT, USA

    Elizabeth Richardson

Authors
  1. Elizabeth Richardson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Scott Fink
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jessica Fried
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elizabeth Richardson .

Editor information

Editors and Affiliations

  1. Medical Director, Capital Health Cancer Center, Director, CH Pancreas Center of Excellence, Director, CH Liver Center of Excellence, Pennington, NJ, USA

    Cataldo Doria

  2. Director of Interventional Gastroenterology, Capital Health Medical Center, Pennington, NJ, USA

    Jason N. Rogart

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Richardson, E., Fink, S., Fried, J. (2022). Clinical Presentation, Diagnosis, and Management of Uncommon Liver Tumors. In: Doria, C., Rogart, J.N. (eds) Hepato-Pancreato-Biliary Malignancies. Springer, Cham. https://doi.org/10.1007/978-3-030-41683-6_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-41683-6_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-41682-9

  • Online ISBN: 978-3-030-41683-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation